Chronic Kidney Disease Clinical Trial
Official title:
Improving Patient Quality of Life and Caregiver Burden by a Peer-Led Mentoring Program for Patients With Chronic Kidney Disease and Their Caregivers
Receiving supportive mentoring from well-adjusted individuals who share similar experiences
has had a positive influence on adjustment with some chronic diseases. In this study,
patients with advanced chronic kidney disease and caregivers of such patients will be
randomly assigned to one of three groups: (1) face-to-face PFPP—individuals will receive six
months of PFPP peer-mentoring, along with an informational text; (2) online PFPP—individuals
will receive six months of online peer-mentoring modeled after the PFPP program, along with
an informational text; and (3) information-only control group—individuals will receive the
text of the material provided to the other two groups. The study team's decision to include
an online version is based on suggestions by previous participants who indicated that this
would be convenient for individuals for whom distance and geographic location are major
considerations of participation.
The investigators expect that both face-to-face and online peer-mentorship programs will
result in improved quality of life among patients with advanced kidney disease and decreased
feeling of burden among caregivers of these patients. The investigators also expect that
mentorship will lead to improved engagement of patients in their own care.
Chronic kidney disease is very common in the United States, and throughout the world. An
increasing number of individuals are diagnosed with late stages of chronic kidney disease,
which require treatment with either dialysis or kidney transplant. The number of individuals
currently requiring such treatment in the United States is greater than 600,000. Patients
with advanced kidney disease and their family members face many challenges in dealing with
the disease and the decisions that relate to choice of treatment. Quite frequently, patients
and their family members are faced with the need to decide on a treatment option without full
awareness of all the options. In such cases, they might make choices with which they will not
be satisfied. Poor satisfaction with treatment choice is likely to result in poor quality of
life for the patients and increased sense of burden for the caregiver.
Receiving supportive mentoring from well-adjusted individuals who share similar experiences
has had a positive influence on adjustment with some chronic diseases. Since 2004, the Kidney
Foundation of Central Pennsylvania has conducted a program to formally train patients with
kidney disease and their caregivers to become mentors for patients or caregivers who feel
they might benefit from such mentoring. The program, the Patient and Family Partner Program
(PFPP), was envisioned and designed by a patient with chronic kidney disease and has trained
approximately 130 mentors.
In this study, patients with advanced chronic kidney disease and caregivers of such patients
will be randomly assigned to one of three groups: (1) face-to-face PFPP—individuals will
receive six months of PFPP peer-mentoring, along with an informational text; (2) online
PFPP—individuals will receive six months of online peer-mentoring modeled after the PFPP
program, along with an informational text; and (3) information-only control group—individuals
will receive the text of the material provided to the other two groups. The study team's
decision to include an online version is based on suggestions by previous participants who
indicated that this would be convenient for individuals for whom distance and geographic
location are major considerations of participation.
The investigators expect that both face-to-face and online peer-mentorship programs will
result in improved quality of life among patients with advanced kidney disease and decreased
feeling of burden among caregivers of these patients. The investigators also expect that
mentorship will lead to improved engagement of patients in their own care.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
| Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
| Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
| Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
| Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
| Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|
||
| Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
| Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
| Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
| Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
| Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
| Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
| Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
| Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
| Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
| Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
| Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
| Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 |